Primary |
Sinusitis |
28.6% |
Lower Respiratory Tract Infection |
14.3% |
Pain |
14.3% |
Pruritus |
14.3% |
Sleep Disorder |
14.3% |
Urticaria |
14.3% |
|
Sedation |
20.0% |
Drug Abuse |
13.3% |
Somnolence |
13.3% |
Atrial Fibrillation |
6.7% |
Dyspnoea |
6.7% |
Lip Swelling |
6.7% |
Memory Impairment |
6.7% |
Nervous System Disorder |
6.7% |
Rib Fracture |
6.7% |
Unresponsive To Stimuli |
6.7% |
Venoocclusive Liver Disease |
6.7% |
|
Secondary |
Product Used For Unknown Indication |
61.4% |
Drug Use For Unknown Indication |
13.9% |
Breast Cancer |
5.1% |
Evidence Based Treatment |
3.8% |
Itchy Rash |
1.9% |
Oropharyngeal Pain |
1.9% |
Rash Pruritic |
1.9% |
Ankle Sprain |
1.3% |
Bronchitis |
1.3% |
Dermatitis Infected |
1.3% |
Ligament Sprain |
1.3% |
Swelling |
1.3% |
Accidental Exposure |
0.6% |
Blood Cholesterol Increased |
0.6% |
Drug Exposure During Pregnancy |
0.6% |
Itching |
0.6% |
Pruritus |
0.6% |
Type Iia Hyperlipidaemia |
0.6% |
|
Toxicity To Various Agents |
20.4% |
Death |
10.2% |
Drug Abuse |
6.1% |
Intentional Drug Misuse |
6.1% |
Tachycardia |
6.1% |
Unresponsive To Stimuli |
6.1% |
Wrong Drug Administered |
6.1% |
Drug Toxicity |
4.1% |
Hypotension |
4.1% |
Metastases To Bone |
4.1% |
Pyrexia |
4.1% |
Respiratory Arrest |
4.1% |
Skin Exfoliation |
4.1% |
Cleft Palate |
2.0% |
Completed Suicide |
2.0% |
Drug Hypersensitivity |
2.0% |
Dyspnoea |
2.0% |
Intentional Overdose |
2.0% |
No Adverse Event |
2.0% |
Overdose |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
27.5% |
Chronic Lymphocytic Leukaemia |
19.0% |
Premedication |
6.7% |
Prophylaxis |
6.7% |
Pain |
6.3% |
Nausea |
3.3% |
Antifungal Prophylaxis |
2.9% |
Diarrhoea |
2.9% |
Diffuse Large B-cell Lymphoma |
2.8% |
Hypertension |
2.8% |
Colorectal Cancer Metastatic |
2.6% |
Pyrexia |
2.5% |
Hypersensitivity |
2.3% |
Graft Versus Host Disease |
2.2% |
Sarcoma |
2.0% |
Acute Myeloid Leukaemia |
1.8% |
Stomatitis |
1.6% |
Breast Cancer |
1.4% |
Gastric Cancer |
1.4% |
Urticaria |
1.4% |
|
Febrile Neutropenia |
14.0% |
Renal Failure Acute |
8.6% |
Tachycardia |
8.6% |
Neutropenic Sepsis |
6.5% |
Mobility Decreased |
5.4% |
Thrombocytopenia |
5.4% |
Congenital Anomaly |
4.3% |
Drug Ineffective |
4.3% |
Lung Infection |
4.3% |
Sepsis |
4.3% |
Suicidal Ideation |
4.3% |
Vomiting |
4.3% |
Hyponatraemia |
3.2% |
Infection |
3.2% |
Injection Site Reaction |
3.2% |
Pneumonia |
3.2% |
Psoriasis |
3.2% |
Pyrexia |
3.2% |
Rash |
3.2% |
Rash Maculo-papular |
3.2% |
|
Interacting |
Epilepsy |
83.3% |
Seasonal Allergy |
16.7% |
|
Toxicity To Various Agents |
100.0% |
|